1-11 of 11
ELISABETH SOUHAMI
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

833-P: Impact of Hypoglycemia on Insulin Titration and Fasting Plasma Glucose in Basal Insulin–Treated Type 2 Diabetes: A Subanalysis of the SoliMix Trial

FRANCESCO GIORGINO, JULIO ROSENSTOCK, ROBERT RITZEL, OGUZHAN DEYNELI, AGUSTINA ALVAREZ, ELISABETH SOUHAMI, LYDIE MELAS-MELT, RORY J. MCCRIMMON
Journal: Diabetes
Diabetes 2022;71(Supplement_1):833-P
DOI: https://doi.org/10.2337/db22-833-P
Published: 01 June 2022
View article
Meeting Abstracts

850-P: Greater HbA1c Reduction with iGlarLixi vs. Insulin Glargine and Lixisenatide Regardless of Levels at Screening: Subgroup Analysis of the LixiLan-O Asia Pacific Trial

YIFAN HE, WENYING YANG, DONG XIAOLIN, GUOYUE YUAN, MING LIU, JIANZHONG XIAO, SHENGHONG GU, LIJUAN CHEN, ELISABETH SOUHAMI
Journal: Diabetes
Diabetes 2022;71(Supplement_1):850-P
DOI: https://doi.org/10.2337/db22-850-P
Published: 01 June 2022
View article
Meeting Abstracts

1-LB: Advancing Therapy in Basal Insulin Users with Type 2 Diabetes (T2D): Hypoglycemia as a Function of HbA1c in the SoliMix Trial

RORY J. MCCRIMMON, PHILIP HOME, ALICE Y. CHENG, FRANCESCO GIORGINO, VIVIAN FONSECA, ELISABETH SOUHAMI, AGUSTINA ALVAREZ, ANDERS H. BOSS, LYDIE MELAS-MELT, JULIO ROSENSTOCK
Journal: Diabetes
Diabetes 2021;70(Supplement_1):1-LB
DOI: https://doi.org/10.2337/db21-1-LB
Published: 01 June 2021
View article
Meeting Abstracts

748-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe

ALICE Y. CHENG, RORY J. MCCRIMMON, VIVIAN FONSECA, CARLOS TRESCOLI, MARTIN HALUZIK, JOCHEN SEUFERT, AGUSTINA ALVAREZ, ELISABETH SOUHAMI, PASCALINE PICARD, MIREILLE BONNEMAIRE, JULIO ROSENSTOCK
Journal: Diabetes
Diabetes 2021;70(Supplement_1):748-P
DOI: https://doi.org/10.2337/db21-748-P
Published: 01 June 2021
View article
Meeting Abstracts

749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe

VIVIAN FONSECA, JULIO ROSENSTOCK, ALICE Y. CHENG, RIFAT EMRAL, LEOBARDO SAUQUE-REYNA, VISWANATHAN MOHAN, SAUD N. AL SIFRI, AGUSTINA ALVAREZ, KHIER DJABALLAH, PASCALINE PICARD, ELISABETH SOUHAMI, RORY J. MCCRIMMON
Journal: Diabetes
Diabetes 2021;70(Supplement_1):749-P
DOI: https://doi.org/10.2337/db21-749-P
Published: 01 June 2021
View article
Meeting Abstracts

746-P: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Nocturnal Hypoglycemia in the SoliMix Trial

RORY J. MCCRIMMON, ALICE Y. CHENG, VIVIAN FONSECA, RICARDO CHOZA, THAMER ALESSA, AGUSTINA ALVAREZ, ELISABETH SOUHAMI, ANDERS H. BOSS, PASCALINE PICARD, JULIO ROSENSTOCK
Journal: Diabetes
Diabetes 2021;70(Supplement_1):746-P
DOI: https://doi.org/10.2337/db21-746-P
Published: 01 June 2021
View article
Meeting Abstracts

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

JULIO ROSENSTOCK, AMAR ALI, JURIS J. MEIER, FRANCESCO GIORGINO, CRISTIAN GUJA, MARTIN PRAZNY, ROBERT LUBWAMA, ELISABETH SOUHAMI, LAWRENCE BLONDE
Journal: Diabetes
Diabetes 2020;69(Supplement_1):88-LB
DOI: https://doi.org/10.2337/db20-88-LB
Published: 01 June 2020
View article
Meeting Abstracts

1139-P: Influence of Screening HbA1c Levels on Glucose Control Achieved when Switching to iGlarLixi in T2D Inadequately Controlled on GLP-1RA and OAD(s)

STEFANO DEL PRATO, LAWRENCE BLONDE, ROBERT R. HENRY, VANITA R. ARODA, NAIM SHEHADEH, ELISABETH NIEMOELLER, ELISABETH SOUHAMI, JUNLONG WU, XIANGLING WANG, CHEN JI, JULIO ROSENSTOCK
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1139-P
DOI: https://doi.org/10.2337/db19-1139-P
Published: 01 June 2019
View article
Meeting Abstracts

1134-P: Efficacy of iGlarLixi in Adults with Type 2 Diabetes Inadequately Controlled on Two or More Oral Antidiabetic Agents

NEIL SKOLNIK, ELISABETH NIEMOELLER, ELISABETH SOUHAMI, LUIGI MENEGHINI
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1134-P
DOI: https://doi.org/10.2337/db19-1134-P
Published: 01 June 2019
View article
Meeting Abstracts

1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial

JULIO ROSENSTOCK, LAWRENCE BLONDE, STEFANO DEL PRATO, ROBERT R. HENRY, NAIM SHEHADEH, ELISABETH NIEMOELLER, ELISABETH SOUHAMI, JUNLONG WU, XIANGLING WANG, CHEN JI, VANITA R. ARODA
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1146-P
DOI: https://doi.org/10.2337/db19-1146-P
Published: 01 June 2019
View article
Meeting Abstracts

149-OR: LixiLan-G: A Randomized Trial Assessing Switching to iGlarLixi vs. Continuation of Daily or Weekly GLP-1RA in T2D Inadequately Controlled by a GLP-1RA and OAD(s)

LAWRENCE BLONDE, JULIO ROSENSTOCK, STEFANO DEL PRATO, ROBERT R. HENRY, NAIM SHEHADEH, ELISABETH NIEMOELLER, ELISABETH SOUHAMI, JUNLONG WU, XIANGLING WANG, CHEN JI, VANITA R. ARODA
Journal: Diabetes
Diabetes 2019;68(Supplement_1):149-OR
DOI: https://doi.org/10.2337/db19-149-OR
Published: 01 June 2019
View article